Physician profile
Vincent Tupper
NPI 1609139583
$7,189.71
in general payments reported to CMS, 2019-2025
13 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,779 · 2020: $1,011 · 2021: $602 · 2022: $721 · 2023: $239 · 2024: $732 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,951.09 | 2019-2025 | Proclaim, Eterna |
| Vertiflex, INC. | $1,030.03 | 2019 | |
| Boston Scientific Corporation | $928.53 | 2019-2021 | |
| Stratus Medical, LLC | $302.21 | 2025 | Nimbus |
| Medtronic, INC. | $206.86 | 2024 | Intellis Adaptivestim |
| Globus Medical, INC. | $191.39 | 2025 | Senza |
| Abbvie INC. | $182.47 | 2024-2025 | |
| Spr Therapeutics, INC | $162.77 | 2025 | Sprint Pns System |
| Vertos Medical, INC. | $121.07 | 2020 | |
| Stryker Corporation | $42.80 | 2023 | Spinejack |
| Nevro Corp. | $32.98 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $22.65 | 2024 | Bridion |
| Collegium Pharmaceutical, INC. | $14.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Tupper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.